Glaucoma is a disease in which the optic nerve is damaged, leading to progressive, irreversible loss of vision. It is often, but not always, associated with increased pressure ...
A US-based non-profit organization, with details of education activities, research findings, and background health information.
Get information about glaucoma and its symptoms, signs, and causes. Learn about treatment, prevention, and research on the leading cause of blindness.
Glaucoma causes, tests, symptoms and treatment; also glaucoma news, FAQ and eye doctor Q-and-A about glaucoma.
Learn About Glaucoma. Glaucoma leads to blindness by damaging the optic nerve. Elevated pressure in the eye is a risk factor, but even people with normal pressure can lose ...
Publication about the risk of getting open-angle glaucoma. Encourages regular eye exams through dilated pupils.
Glaucoma — Comprehensive overview covers symptoms, causes, treatment of this eye condition that threatens vision.
Learn about glaucoma, including types, symptoms, risk factors, diagnosis, and treatment.
Glaucoma damages the eye's optic nerve. It is a leading cause of blindness in the United States. It usually happens when the fluid pressure inside the eyes slowly rises ...
Glaucoma, a disease that damages the optic nerve, affects over three million Americans. Examine the symptoms and signs of glaucoma and learn more about what causes the disease ...

An experience that opened my eyes Asheville Citizen-Times Glaucoma? Macular degeneration? Or realizing my worst fears, spending the rest of my days looking like Harry Potter? As I stammered over the letters in the ...

A boost for eye care in city Express Buzz The major highlights of the institution are the four exclusive state-of-the-art clinics: for Glaucoma, Retina, Cornea and Squint. ...

Can-Fite BioPharma opens IND with US-FDA for CF101 Phase 3 study in Dry Eye ... News-Medical.net These findings have prompted the company to initiate a Phase 2 clinical study in patients with Glaucoma which is currently ongoing with CF101. and more »

Watson files for eye medicine patent Press-Enterprise The medication reduces the pressure caused by glaucoma in certain patients. The patent infringement suit was filed by Allegan Inc. last week in federal ... and more »

CytRx Initiates Phase 2 Clinical Trial with Bafetinib in Advanced Prostate Cancer PipelineReview.com (press release) These findings have prompted the company to initiate a Phase 2 clinical study in patients with Glaucoma which is currently ongoing with CF101. ... and more »

Promedior Announces Publication of New Research Demonstrating Pentraxin-2/SAP ... PipelineReview.com (press release) ... lung and kidney such as glaucoma, age-related macular degeneration, diabetic retinopathy and dry eye disease (eye); pulmonary fibrosis, scleroderma and ... and more »

The Star-Ledger - NJ.com

Community activist Rev. Daughtry comes to Jersey City to prevent eviction The Star-Ledger - NJ.com Aside from having a degenerative bone disease, she has glaucoma, heart problems, a new hip and is required to have a home health aide seven days a week. ...

Sylentis Receives Authorization to Commence a New Phase I/II Clinical Trial ... PR Newswire (press release) It has proven effective in diminishing intraocular pressure in animal models in vivo and also in preventing glaucoma, and was found to be superior to the ... and more »

Sylentis Receives Authorization to Commence a New Phase I/II Clinical Trial ... Sacramento Bee It has proven effective in diminishing intraocular pressure in animal models in vivo and also in preventing glaucoma, and was found to be superior to the ... and more »

Sylentis Receives Authorization to Commence a New Phase I/II Clinical Trial ... FierceBiotech It has proven effective in diminishing intraocular pressure in animal models in vivo and also in preventing glaucoma, and was found to be superior to the ... and more »